Reneo Pharmaceuticals, Inc. (RPHM) Reports Q2 Loss of $0.16

Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) reported Q2 EPS of ($0.16), versus ($0.65) reported last year.

For earnings history and earnings-related data on Reneo Pharmaceuticals, Inc. (RPHM) click here.

You May Also Be Interested In

• Cinema United: issues joint letter to state AGs and Paramount
• 374Water Inc (SCWO) Misses Q2 EPS by 15c
• Boeing-Lockheed’s ULA triples bond sale to $1.5 billion - report